Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Giulia Cheloni, B.M., Ph.D.

Concepts (109)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Giulia Cheloni's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Giulia Cheloni has written about over time.
Fusion Proteins, bcr-abl, 4 publications between 2014 and 2016, average publication date January 2015. Macrolides, 2 publications between 2015 and 2016, average publication date July 2015. Drug Resistance, Neoplasm, 3 publications between 2014 and 2016, average publication date July 2015. Drug Screening Assays, Antitumor, 1 publications between 2016 and 2016, average publication date January 2016. Stem Cell Niche, 2 publications between 2014 and 2019, average publication date July 2016. K562 Cells, 2 publications between 2016 and 2017, average publication date September 2016. Neoplastic Stem Cells, 9 publications between 2014 and 2020, average publication date November 2016. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 7 publications between 2014 and 2020, average publication date January 2017. Acriflavine, 1 publications between 2017 and 2017, average publication date June 2017. Drug Delivery Systems, 1 publications between 2017 and 2017, average publication date June 2017. Hypoxia-Inducible Factor 1, 1 publications between 2017 and 2017, average publication date June 2017. Neoplasm Proteins, 1 publications between 2017 and 2017, average publication date June 2017. Leukemia, Myeloid, Acute, 4 publications between 2013 and 2021, average publication date March 2018. Neoplasms, Experimental, 2 publications between 2017 and 2019, average publication date May 2018. Cell Hypoxia, 1 publications between 2019 and 2019, average publication date January 2019. Leukemia, 1 publications between 2019 and 2019, average publication date January 2019. Leukemia, Promyelocytic, Acute, 2 publications between 2019 and 2021, average publication date March 2020. Cancer Vaccines, 2 publications between 2021 and 2022, average publication date December 2021.

To see the data from this visualization as text, click here.
Cheloni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (109)
Explore
_
Co-Authors (39)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.